By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan

PRNW Agency
Last updated: 04/03/2025 1:54 PM
PRNW Agency
Share
5 Min Read
DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan
SHARE
DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan

Leading the Way in Healthcare Innovation Across the Medication Journey

SAN ANTONIO, March 3, 2025 /PRNewswire/ — DrFirst, a leading innovator in healthcare technology, has been honored with the prestigious Enabling Technology Leadership Award by Frost & Sullivan. This recognition highlights how the outstanding contributions of DrFirst bridge critical gaps in healthcare through groundbreaking technology solutions. With its comprehensive platform, DrFirst optimizes the medication journey from prescribing to adherence, with integrated solutions that directly address critical challenges in prescription management and orchestration; medication access, affordability, and adherence; and clinical data accuracy.

The U.S. healthcare market has long struggled with entrenched resistance to change, resulting in isolated healthcare information systems that hinder collaboration. Limited interoperability has led to inefficiencies, medication errors, and unnecessary hospital readmissions. In response to these challenges, DrFirst has developed a holistic, technology-driven approach that empowers healthcare professionals and patients with real-time access to accurate patient information, enhancing decision-making and improving outcomes.

DrFirst has pioneered innovative solutions that integrate with electronic health records (EHRs), health information exchanges (HIEs), and pharmacy systems, simplifying workflows and transforming how providers, pharmacists, and other stakeholders collaborate for high-quality patient care.

- Advertisement -

Key achievements that contributed to this award include:

  • Prescription Orchestration Technology — The company’s latest innovation reinvents how ePrescriptions are shared between providers, pharmacies, and payers, enabling clinical collaboration and custom workflows that speed access to specialty medications.
  • AI-Powered Solutions — Using artificial intelligence and real-time data sharing, DrFirst innovations minimize prescription errors and boost clinical workflow efficiency.
  • Patient Engagement and Adherence — DrFirst digital tools empower patients with cost-saving and educational resources, prescription price transparency, and access to patient support, lowering prescription abandonment.
  • Medication Reconciliation Excellence — The company improves the accuracy of medication history, significantly reducing adverse drug events and hospital readmissions.

“Innovation is not just about technology—it’s about empowering people,” said G. Cameron Deemer, DrFirst CEO. “This recognition from Frost & Sullivan underscores our culture of innovation and commitment to eliminating friction in medication management for all stakeholders in healthcare, ultimately achieving better medication outcomes for everyone.”

Through strategic partnerships with over 2,000 hospitals, 270 EHR systems, and 70,000 pharmacies, DrFirst solutions reach 100 million patients annually. The company’s collaborative approach fosters a healthcare ecosystem where providers can make informed, timely decisions while mitigating costs and inefficiencies.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features, functionality, and rapidly growing market acceptance. The award recognizes the solution’s quality and the customer value it delivers.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

- Advertisement -

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

About DrFirst
For 25 years, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare workflows and help patients start and stay on therapy with end-to-end solutions that enhance prescription access, affordability, and adherence. DrFirst has recently won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions help 100 million patients a year and are used by more than 420,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit DrFirst.com and follow @DrFirst.

- Advertisement -

Contact:

Camila Tinajero
P: +54911 6713 2748
E: Camila.Tinajero@frost.com 

View original content:https://www.prnewswire.co.uk/news-releases/drfirst-recognized-for-enabling-technology-leadership-in-healthcare-by-frost–sullivan-302389297.html

You Might Also Like

CryptoBox Revolutionizes Crypto Staking with AI-Driven Liquidity Solutions

Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends

Ministry of Technology and Science of Zambia and Huawei Jointly Launch the Global Smart Village Showcase, Exploring New Digital Transformation Modes for Villages

Introducing $DIDDY: The Meme Token Making Waves on Solana

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

TAGGED:accessacrossadherenceantonioawardchallengescontributionscriticaldrfirstenablingfrosthealthcarehighlightshonoredinformationInnovationinnovatorjourneyleadershipleadingmarchmedicationoutstandingprestigiousrecognitionrecognizedsansolutionssullivanTechnologyuncategorizedway

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat’s Gut Microbiome Effects from Other Anti-CDI Antibiotics
Next Article ELLKAY Names Ajay Kapare CEO ELLKAY Names Ajay Kapare CEO

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

MEXC Hits 40M Users with 46% Growth in New Listing Token Trading Volume in May
MEXC Hits 40M Users with 46% Growth in New Listing Token Trading Volume in May
Business 09/06/2025
BingX and Chelsea FC Unveil 25/26 Training Kit with “Trained on Greatness” Campaign
BingX and Chelsea FC Unveil 25/26 Training Kit with “Trained on Greatness” Campaign
Business 09/06/2025
DrFirst Recognized for Enabling Technology Leadership in Healthcare by Frost & Sullivan
Quantel Asset Management and Sincere Syndication Announce Strategic Partnership to Unlock U.S.-India Cross-Border Investment Opportunities
Business 09/06/2025
$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed
$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed
Tech 09/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?